Immune parameters and outcomes during Ebola virus disease
Authors:
- Stéphanie ReynardSRStéphanie Reynard
- Alexandra JourneauxAJAlexandra Journeaux
- Emilie GloaguenEGEmilie Gloaguen
- Justine SchaefferJSJustine Schaeffer
- Hugo VaretHVHugo Varet
- Natalia PietrosemoliNPNatalia Pietrosemoli
- Mathieu MateoMMMathieu Mateo
- Nicolas BailletNBNicolas Baillet
- Jimmy MullaertJMJimmy Mullaert
- Sylvain BaizeSBSylvain Baize
Open Access
- 10 January 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (1)
Abstract
BACKGROUND. The West African Ebola virus epidemic from 2014–2016 highlighted the lack of knowledge about the pathogenicity of the virus and the factors responsible for outcome. A performant and rapid diagnosis is of crucial importance, as is overcoming the difficulty of providing high-quality patient management during such an extensive outbreak. Here, we propose to study the role of the immune mediators during Ebola virus disease and to define some molecules of importance in the outcome. METHODS. Plasma from Guinean patients sampled during the outbreak were analyzed using RT-qPCR, magnetic bead assay, ELISA, and high-quality statistical analyses. We also performed a transcriptomic analysis in leukocytes samples. Therefore, we deeply characterized the immune responses involved in Ebola virus disease. RESULTS. We evaluated the immune patterns depending on the outcome of the disease. Survivors presented an efficient and well-balanced immune response, whereas fatalities were characterized by an intense inflammatory response, overexpression of multiple cytokines, and a “chemokine storm.” The plasma concentration of most of the parameters tested increased until death. Statistical analyses also allowed us to define a panel of markers highly predictive of outcome. CONCLUSION. The immune response observed in fatalities was highly similar to that characterizing septic shock syndrome. Our results suggest that immune responses can play a major pathogenic role during severe Ebola virus infection and argue in favor of therapeutic approaches that act on both viral replication and the induction of shock syndrome. FUNDING. French Ministry of Foreign Affairs, the Agence Française de Développement, and the Institut Pasteur.Keywords
Funding Information
- Institut Pasteur de Tunis (Grant from the Ebola Taskforce)
- Agence Française de Développement (Funding for the Macenta Laboratory)
- French Ministry of Foreign Affairs (Funding for the Macenta Laboratory)
This publication has 58 references indexed in Scilit:
- Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, GuineaJCI Insight, 2017
- Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort studyThe Lancet Infectious Diseases, 2015
- Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in GuineaClinical Infectious Diseases, 2015
- Clinical Illness and Outcomes in Patients with Ebola in Sierra LeoneNew England Journal of Medicine, 2014
- Blood Chemistry Measurements andd‐Dimer Levels Associated with Fatal and Nonfatal Outcomes in Humans Infected with Sudan Ebola VirusThe Journal of Infectious Diseases, 2007
- Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide LevelsJournal of Virology, 2004
- Inflammatory responses in Ebola virus-infected patientsClinical and Experimental Immunology, 2002
- Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patientsNature Medicine, 1999
- Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus InfectionThe Journal of Infectious Diseases, 1999
- The pathology of experimental Ebola virus infection in monkeysThe Journal of Pathology, 1978